Expertise
The global healthcare sector comprises a vast number of companies who develop and market drugs and devices and provide services aimed at improving the quality of life for people.
Healthcare is among the most highly regulated industries, and every country exercises control over the approval of new therapies and diagnostics, as well as the provision of primary and acute treatment and social care services within its jurisdiction.
The Mergers Alliance healthcare team has a unique understanding of the industry and expertise to help our clients navigate the various country-specific issues as well as being able to provide comprehensive support in the execution of their global M&A strategies. We provide advice on M&A, equity and debt financing and portfolio strategy to a wide range of healthcare companies and private equity firms around the world.
Please contact Stas Michael for more information or select a contact in a specific location.
Consolidation trends in Brazilian pharmaceutical retail The pharmaceutical retail sector, one of the fastest growing segments in the Brazilian economy, has been going through a strong consolidation process More...
Clinical research organisation market projected to grow globally at 8.5%, UK an attractive marketThe CRO market projected to grow globally at 8.5% CAGR to $32.7bn by 2015, outstripping the growth of the pharmaceuticals industry. More...
Shalaks PharaceuticalsShalaks Pharmaceuticals Pvt. Ltd. is a very profitable Delhi based Pharmaceutical Company, which has been in more...
Biologici Italia LaboratoriesEthica Corporate Finance advised Biologici Italia Laboratories (BIL) in the acquisition of Liosintex, a company active more...